ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Healthcare Shares
How high could the ResMed share price climb?
Share Market News
3 ASX shares this fund manager thinks are compelling buys right now
Share Market News
Here's how the ASX 200 market sectors stacked up this week
Blue Chip Shares
Morgans says these ASX 50 shares are strong buys
Opinions
5 ASX shares I think you can confidently invest $500 in right now
Dividend Investing
What's happening with the ResMed share price on Wednesday?
Healthcare Shares
Own Resmed shares? Here are 3 impactful points from the results of its feared disruptor
Cheap Shares
'Long and bullish': 2 classic ASX 200 shares to buy while they're still cheap
Opinions
Don't look now, but these 3 ASX shares look poised for a nice rally
Share Gainers
'Appealing outlook': 2 ASX 200 shares that just started their latest rally
Healthcare Shares
Hoping to bag the ResMed dividend? You better be quick!
Broker Notes
Top brokers name 3 ASX shares to buy next week
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
